Unbiased

Four different archaeal genes expressed in (1) BL21-Gold (DE3) or (2) BL21-CodonPlus (DE3)-RIL Cells To clone or not to clone is seldom the question in today's fast-paced genetics research laboratory--cloning inevitably wins out. Past obstacles faced by the early recombinant DNA research community, such as finding acceptable hosts and vectors and isolating the desired genetic material, have since been worked out and replaced with the struggle to get optimal expression of those clones. Escheric

Written byDebra Swanson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share


Four different archaeal genes expressed in (1) BL21-Gold (DE3) or (2) BL21-CodonPlus (DE3)-RIL Cells
To clone or not to clone is seldom the question in today's fast-paced genetics research laboratory--cloning inevitably wins out. Past obstacles faced by the early recombinant DNA research community, such as finding acceptable hosts and vectors and isolating the desired genetic material, have since been worked out and replaced with the struggle to get optimal expression of those clones.

Escherichia coli have long been a favorite host for their simple, rapid, and economical propagation. But heterologous protein expression in prokaryotic cells can have certain drawbacks, including toxicity of the foreign protein and low yields. Codon bias problems can occur when codons that are seldom used in endogenous E. coli genes are found frequently in the foreign gene. This situation is not uncommon when expressing human genes in bacterial hosts and can result in low recombinant protein ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies